Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments.
Alstrup, Morten; Meyer, Jeppe; Schultz, Martin; Rasmussen, Line Jee Hartmann; Rasmussen, Lars Simon; Køber, Lars; Forberg, Jakob Lundager; Eugen-Olsen, Jesper; Iversen, Kasper.
World J Surg
; 43(3): 780-790, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30390135
SuPAR, an emerging biomarker in kidney and inflammatory diseases.
Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study.
Akut apandisitte serum ürokinaz-tipi plazminojen aktivatör reseptörünün tanisal degeri.
Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality.
Soluble Urokinase Receptor and Chronic Kidney Disease.
Serum soluble urokinase-type plasminogen activator receptor as a serum marker of inflammatory response that leads to tissue damage and surgical complication.
Biochemical markers of inflammation are associated with increased mortality in hip fracture patients: the Bispebjerg Hip Fracture Biobank.
Has the circulating permeability factor in primary FSGS been found?
The clinical pattern of nephrotic syndrome in children has no effect on the concentration of soluble urokinase receptor (suPAR) in serum and urine.
Can serum soluble urokinase plasminogen activator receptor be an effective marker in the diagnosis of appendicitis and differentiation of complicated cases?